MCG for Risk Stratifications of Patients With Chest Pain
Magnetocardiography in the Identification and Risk Stratification of Patients With Acute Chest Pian
1 other identifier
observational
3,620
1 country
1
Brief Summary
This prospective cohort study is aimed at identification and risk stratification of patients who have symptoms of acute chest pain suspected with acute coronary syndrome (ACS) using Magnetocardiography (MCG).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 11, 2024
CompletedFirst Posted
Study publicly available on registry
March 18, 2024
CompletedStudy Start
First participant enrolled
March 20, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedSeptember 3, 2024
February 1, 2024
7 months
March 11, 2024
August 29, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
Efficacy of MCG for the detection and risk stratification in high-risk patients with chest pain
Establishing an algorithm model of MCG in identifying high-risk cardiogenic chest pain, the efficacy of the model was assessed by sensitivity, specificity, accuracy, positive predictive value, negative predictive value, and AUC, etc.
from the date of enrollment until the date of discharge, up to 30 days
Efficacy of MCG for the detection and risk stratification in low-risk patients with chest pain
Establishing an algorithm model of MCG in identifying low-risk cardiogenic chest pain, the efficacy of the model was assessed by sensitivity, specificity, accuracy, positive predictive value, negative predictive value, and AUC, etc.
from the date of enrollment until the date of discharge, up to 30 days
Study Arms (2)
Training and testing cohort
External validation cohort
Interventions
Eligibility Criteria
patient who suffers from cardiogenic chest pain suspected with acute coronary syndrome (ACS).
You may qualify if:
- Those with suspected ACS who presented with symptoms of acute chest pain.
- Signed informed consent.
You may not qualify if:
- Those with known structural heart disease such as cardiomyopathy and valvular disease;
- Those with atrial fibrillation, supraventricular tachycardia, atrioventricular block and other arrhythmias that have not returned to normal;
- Those who have chest pain with known pulmonary embolism or aortic coarctation;
- Those who are thought to be incapable of completing the MCG examination by an attending physician (or physician with higher qualifications) due to unstable clinical conditions, metal implants, etc;
- Those who are unable to perform magnetocardiography examinations due to claustrophobia, etc., or those who fail to receive magnetocardiography examination;
- Those with malignant tumors;
- Pregnant or lactating women.
- Those with acute or critical illnesses of other systems, such as acute or severe respiratory illnesses, marked abnormalities in liver function or kidney function.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Qilu Hospital of Shandong Universitylead
- Chongqing Emergency Medical Centercollaborator
- Weifang People's Hospitalcollaborator
- Linyi People's Hospitalcollaborator
- Weihai Central Hospitalcollaborator
- Jining First People's Hospitalcollaborator
- The First Affiliated Hospital with Nanjing Medical Universitycollaborator
- Second Affiliated Hospital, School of Medicine, Zhejiang Universitycollaborator
- First Affiliated Hospital Xi'an Jiaotong Universitycollaborator
- First People's Hospital of Hangzhoucollaborator
- Guangdong Provincial Hospital of Traditional Chinese Medicinecollaborator
- Qianfoshan Hospitalcollaborator
- Heze Municipal Hospitalcollaborator
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen Universitycollaborator
Study Sites (1)
Qilu Hospital of Shandong University
Jinan, Shandong, 250012, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yuguo Chen, Professor
Qliu Hospital of Shandong University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 11, 2024
First Posted
March 18, 2024
Study Start
March 20, 2024
Primary Completion
October 30, 2024
Study Completion
December 31, 2024
Last Updated
September 3, 2024
Record last verified: 2024-02